PNN
Ahmedabad (Gujarat) [India], June 17: Corona Remedies, an Ahmedabad-based pharmaceutical company dedicated to promoting good health for all, has set an Asia record for screening the most number of patients for peripheral neuropathy using Biothesiometer in a single week. has made.
Recognized by the Asia Book of Records, this remarkable feat was accomplished from May 5 to 11, 2024, which is observed globally as Neuropathy Awareness Week. This achievement underlines the importance of health awareness and highlights the impact of coordinated health efforts.
A team of Corona Remedies screened 21,012 patients with the help of 1,231 doctors at Neuropathy check-up camps across India during the week. The initiative was part of the company's "Mission Heal India" initiative.This included collaboration with local health service providers, clinics and hospitals, and community leaders in urban centres, rural villages and remote areas.
Nirav K, promoter and executive director of Corona Remedies. Mehta said, "This record is about raising awareness and providing early diagnosis to thousands of people who might otherwise suffer silently. Peripheral Neuropathy can significantly impact the quality of life. We are dedicated to peripheral screening. Neuropathy is conducted regularly throughout the year with an aim to educate as many patients as possible about this condition. We aim to bring about a lasting change in the lives of patients through 'Mission Heal India' in collaboration with the wider medical community. Is.,
Peripheral neuropathy affects millions of people globally, especially those with diabetes, endocrine disorders or vitamin B12 deficiency. Factors that contribute to neuropathy include dietary patterns, especially vegetarian or vegan diets that cause vitamin B12 and vitamin D deficiencies, heavy alcohol consumption, exposure to toxins, side effects of certain medications, and genetic disorders. .
Early detection is important for effective management, especially in diabetic patients as 50 percent of such patients have no symptoms of neuropathy. Without timely intervention, the condition can lead to serious complications such as foot ulcers, which may lead to leg amputation.
As well as raising awareness, this unique initiative has provided valuable epidemiological insights.A notable finding is that the prevalence of severe neuropathy is 2.67 times higher and the prevalence of moderate neuropathy is 2.56 times higher in diabetic patients compared to others.
The Asia Book of Records, a major custodian of records for Asian countries, operates under the World Records Union. It cooperates closely with various national record books including Vietnam, Nepal, Cambodia, India, Indo-China, Bangladesh, USA, Ukraine Book and Indonesia. Its headquarters are located in India and Vietnam.
Corona Remedies Pvt Ltd was established in 2004 with a commitment to ensure better health for all.Corona is the youngest and fastest growing company among the top 40 companies in the Indian pharmaceutical market with 30th rank. Corona enjoys leadership positions in women's health, infertility and cardiometabolic and a strong presence in orthopedics.
Corona Remedies manufactures a complete range of healthcare solutions in accordance with international quality standards in its WHO-GMP/EU GMP-approved facility. Corona Remedies has 2 DSIR-approved R&D centres, with over 80 scientific teams working on innovative platform technologies and hormones. Corona Remedies is a proud family of 4500+ employees working tirelessly towards the common goal of good health for all.
Ahmedabad (Gujarat) [India], June 17: Corona Remedies, an Ahmedabad-based pharmaceutical company dedicated to promoting good health for all, has set an Asia record for screening the most number of patients for peripheral neuropathy using Biothesiometer in a single week. has made.
Recognized by the Asia Book of Records, this remarkable feat was accomplished from May 5 to 11, 2024, which is observed globally as Neuropathy Awareness Week. This achievement underlines the importance of health awareness and highlights the impact of coordinated health efforts.
A team of Corona Remedies screened 21,012 patients with the help of 1,231 doctors at Neuropathy check-up camps across India during the week. The initiative was part of the company's "Mission Heal India" initiative.This included collaboration with local health service providers, clinics and hospitals, and community leaders in urban centres, rural villages and remote areas.
Nirav K, promoter and executive director of Corona Remedies. Mehta said, "This record is about raising awareness and providing early diagnosis to thousands of people who might otherwise suffer silently. Peripheral Neuropathy can significantly impact the quality of life. We are dedicated to peripheral screening. Neuropathy is conducted regularly throughout the year with an aim to educate as many patients as possible about this condition. We aim to bring about a lasting change in the lives of patients through 'Mission Heal India' in collaboration with the wider medical community. Is.,
Peripheral neuropathy affects millions of people globally, especially those with diabetes, endocrine disorders or vitamin B12 deficiency. Factors that contribute to neuropathy include dietary patterns, especially vegetarian or vegan diets that cause vitamin B12 and vitamin D deficiencies, heavy alcohol consumption, exposure to toxins, side effects of certain medications, and genetic disorders. .
Early detection is important for effective management, especially in diabetic patients as 50 percent of such patients have no symptoms of neuropathy. Without timely intervention, the condition can lead to serious complications such as foot ulcers, which may lead to leg amputation.
As well as raising awareness, this unique initiative has provided valuable epidemiological insights.A notable finding is that the prevalence of severe neuropathy is 2.67 times higher and the prevalence of moderate neuropathy is 2.56 times higher in diabetic patients compared to others.
The Asia Book of Records, a major custodian of records for Asian countries, operates under the World Records Union. It cooperates closely with various national record books including Vietnam, Nepal, Cambodia, India, Indo-China, Bangladesh, USA, Ukraine Book and Indonesia. Its headquarters are located in India and Vietnam.
Corona Remedies Pvt Ltd was established in 2004 with a commitment to ensure better health for all.Corona is the youngest and fastest growing company among the top 40 companies in the Indian pharmaceutical market with 30th rank. Corona enjoys leadership positions in women's health, infertility and cardiometabolic and a strong presence in orthopedics.
Corona Remedies manufactures a complete range of healthcare solutions in accordance with international quality standards in its WHO-GMP/EU GMP-approved facility. Corona Remedies has 2 DSIR-approved R&D centres, with over 80 scientific teams working on innovative platform technologies and hormones. Corona Remedies is a proud family of 4500+ employees working tirelessly towards the common goal of good health for all.
